Idactamab INT-001 represents the interesting medicinal strategy for managing certain blood-related cancers. The immunoglobulin is a special process of action, specifically targeting CD38, the membrane antigen expressed https://heathwckn574190.aboutyoublog.com/51884043/idacta-mab-int-001-the-new-immunoglobulin-under-testing